Moreover, we identified a new compound that we termed Super-EBS that inhibits the growth of tumors from diverse cancer cell lines resistant to conventional treatments by inhibition of phospho-S6K1 but not total S6K1 protein levels. Here, RPS6KB1 is linked to cancer.